Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PFE compared with MRK: revenue, margins and what each company keeps, and the suppliers and customers both name
PFE
Pfizer Inc
Change
Mkt cap
Revenue
Revenue
MRK
Merck & Co., Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PFE
Pfizer Inc
vs
MRK
Merck & Co., Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes · 499d
Method
›
Moved together
PFE
with
MRK
×0.71
co-movement · MRK on PFE · 499d
r 0.58
scale to r 0.75
Shared co-movers
7
with PFE
with MRK
BMY
Bristol Myers Squibb Co
r 0.60
r 0.52
NVS
Novartis AG
r 0.53
r 0.51
AMGN
Amgen Inc
r 0.58
r 0.50
BIIB
Biogen Inc.
r 0.54
r 0.49
ABBV
AbbVie Inc.
r 0.49
r 0.50
GSK
GSK plc
r 0.53
r 0.48
PFE, solid
MRK, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
PFE
Pfizer Inc
Change
30.71
▲
+0.62%
· post 31.12
· delayed
Mkt cap
$174.0B
Revenue
$15.0B
Q2 FY26
Revenue
$62.6B
FY25
MRK
Merck & Co., Inc.
Change
148.44
▼
−0.72%
· post 148.50
· delayed
After hours
Nov 2 '26
delayed
Mkt cap
$368.9B
Revenue
$16.6B
Q2 FY26
Revenue
$65.0B
FY25
vs
Compare
After hours
Nov 2 '26
delayed
PFE
Pfizer Inc
vs
MRK
Merck & Co., Inc.
30.71
▲
+0.62%
post 31.12
delayed
Price
148.44
▼
−0.72%
post 148.50
delayed
$174.0B
Mkt cap
$368.9B
Q2 FY26
$15.0B
Revenue
$16.6B
Q2 FY26
FY25
$62.6B
Revenue
$65.0B
FY25
Change
Change
PFE
30.71
▲
+0.62%
vs
MRK
148.44
▼
−0.72%
After hours
Nov 2 '26
delayed